Research Projects
Project Overview:
In the ever-evolving realm of immunology, the enigmatic world of non-canonical Human Leukocyte Antigen (HLA)-bound peptides...
Supervisor: Dr Pouya Faridi
A major challenge in cancer therapeutics is to kill tumour cells without harming normal cells in the body. Traditional chemotherapy tries to do this...
Supervisor: Dr Lan Nguyen
Preterm birth is a public health concern, and it has been listed as one of the focuses under the Good Health and Well-Being of The Sustainable...
Supervisor: Dr Jodi Law Woan-Fei
The Next Generation Precision Medicine Program focuses on utilising genetic profiles of patients’ tumour models to identify new therapeutic targets...
Supervisor: Dr Claire Sun
The project: Antigen presenting cells (APCs) play a crucial role in establishing and maintaining an immune response towards cancer cells. In recent...
Supervisor: Professor Anthony Purcell
Psoriasis is a skin autoimmune disease that affects 2-3% of the global population. Around half of the patients carry the major risk gene for...
Supervisor: Dr. Asolina Braun
RNA sequencing technologies enable the simultaneous detection of tens of thousands of genes, providing researchers with a powerful tool for...
Supervisor: Professor Wei Shi
Single-cell analyses are at the leading edge of technological development for cell biology. And, transcriptomics analyses at single-cell resolution...
Supervisor: A/Prof Traude Beilharz
Endometriosis is a chronic disease characterised by growth of cells in ectopic locations and chronic inflammation. This project looks to 1)...
Supervisor: Dr Fiona Cousins
The microbial communities associated with every surface of our bodies are incredibly diverse, yet we know practically nothing about the majority of...
Supervisor: Assoc Prof Sam Forster
Natural products are structurally interesting molecules (metabolites) produced in nature by organisms such as bacteria, fungi and plants. The unique...
Supervisor: Dr. Lauren Murray
Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of...
Supervisor: Professor Patrick Kwan
Anorexia nervosa (AN) has clear biological underpinnings, however, the molecular mechanisms that lead to the development of this debilitating...
Supervisor: Dr Claire Foldi
Androgen deprivation therapy (ADT) is an important last-line treatment for advanced prostate cancer. ADT initially works well but eventually fails in...
Supervisor: Dr Renea Taylor
Enduring antibody-mediated immunity is critical for vaccines to provide protection from infectious disease. Despite the success of vaccines to date,...
Supervisor: Dr Danika Hill
Antimicrobial resistance (AMR) is emerging at an alarming level, rendering some bacterial infections untreatable and increasing dependence on last...
Supervisor: Assoc Prof Sam Forster
We and many others over the last few decades have contributed to a now much improved understanding of the genomic components of familial risk for...
Supervisor: Professor Melissa Southey
The most aggressive forms of prostate cancer demonstrate resistance to multiple types of cancer drugs. We have performed RNA-sequencing on a large...
Supervisor: Dr David Goode
Current therapies for epilepsy are symptomatic, only suppressing the symptoms (seizures), but do not impact the development or progression of disease...
Supervisor: Dr Pablo Casillas-Espinosa MD, PhD
Conventional chemotherapeutic agent, temozolomide (TMZ), for Glioblastoma (GBM) often displays high chemoresistance with various side effects....
Supervisor: Alfarizal Kamarudin